Ubrogepant treatmeNt in mIgraine Patients Utilizing mOnoclonal aNtibodies
Clinical trial NCT05503082 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05503082
- Sponsor
- Chicago Headache Center & Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-06
- Primary completion
- 2024-09-01
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.